Cromwell, CT, United States of America

Brett R Beno

This inventor holds 15 USPTO granted patents and 2 published patent applications and 5 EPO patents, primarily in Pharmaceutical Research. Top assignees: Bristol-Myers Squibb Compnay, Viiv Healthcare UK (No.5) Limited. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett R Beno. Retrieved from https://idiyas.com/inventor/brett-r-beno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 80.0

 

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Cromwell, CT (US) (2006 - 2018)
  • Wallingford, CT (US) (2018 - 2019)
  • Yardley, PA (US) (2022)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Galectin-3 Inhibitors
HIV Replication Inhibitors
Hepatitis C Compounds
Amidoheterocycles
Melanocortin-4 Receptor
Small Molecule Inhibitors
Pharmaceutical Innovations
Drug Development
Therapeutic Compounds
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Brett R Beno

Introduction

Brett R Beno is a prominent inventor based in Cromwell, Connecticut, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Beno has made remarkable strides in developing small molecule inhibitors that target galectin-3, a protein implicated in various diseases.

Latest Patents

Beno's latest patents focus on small molecule inhibitors of galectin-3. The present disclosure relates to compounds of formula I, which inhibit Gal-3, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions. This innovative work has the potential to impact therapeutic approaches for conditions associated with galectin-3.

Career Highlights

Throughout his career, Beno has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Beno has collaborated with esteemed colleagues such as John A Bender and John F Kadow, further enhancing the quality and impact of his work in the field.

Conclusion

Brett R Beno's innovative contributions to the pharmaceutical industry, particularly in the development of galectin-3 inhibitors, highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…